Skip to main content

Publications by Jochen Schwenk

Refereegranskade

Artiklar

[1]
X. Yu et al., "Advances in plasma proteomics : Moving from technology to precision medicine," PROTEOMICS - Clinical Applications, vol. 16, no. 6, 2022.
[2]
[4]
Z. Yang et al., "Genetic Landscape of the ACE2 Coronavirus Receptor," Circulation, vol. 145, no. 18, pp. 1398-1411, 2022.
[6]
X. Yu et al., "Advances in plasma proteomics : Call for papers for an upcoming special issue," PROTEOMICS - Clinical Applications, vol. 15, no. 6, 2021.
[7]
[9]
[10]
M. J. Iglesias et al., "Identification of Endothelial Proteins in Plasma Associated With Cardiovascular Risk Factors," Arteriosclerosis, Thrombosis and Vascular Biology, vol. 41, no. 12, pp. 2990-3004, 2021.
[11]
[14]
R. Bizzotto, J. M. Schwenk and A. Mari, "Processes Underlying Glycemic Deterioration in Type 2 Diabetes : An IMI DIRECT Study," Diabetes Care, vol. 44, no. 2, pp. 511-518, 2021.
[16]
E. W. Deutsch et al., "p Advances and Utility of the Human Plasma Proteome," Journal of Proteome Research, vol. 20, no. 12, pp. 5241-5263, 2021.
[17]
N. Bar et al., "A reference map of potential determinants for the human serum metabolome," Nature, vol. 588, no. 7836, pp. 135-140, 2020.
[19]
Å. Sivertsson et al., "Enhanced Validation of Antibodies Enables the Discovery of Missing Proteins," Journal of Proteome Research, vol. 19, no. 12, pp. 4766-4781, 2020.
[21]
K. Suhre, M. I. McCarthy and J. M. Schwenk, "Genetics meets proteomics : perspectives for large population-based studies," Nature reviews genetics, 2020.
[23]
[26]
M.-G. Hong et al., "Profiles of histidine-rich glycoprotein associate with age and risk of all-cause mortality," Life Science Alliance, vol. 3, no. 10, pp. e202000817, 2020.
[34]
V. Ignjatovic et al., "Mass Spectrometry-Based Plasma Proteomics : Considerations from Sample Collection to Achieving Translational Data," Journal of Proteome Research, vol. 18, no. 12, pp. 4085-4097, 2019.
[35]
E. Lorenzen et al., "Multiplexed analysis of the secretin-like GPCR-RAMP interactome," Science Advances, vol. 5, no. 9, 2019.
[36]
G. S. Omenn et al., "Progress on Identifying and Characterizing the Human Proteome : 2019 Metrics from the HUPO Human Proteome Project," Journal of Proteome Research, vol. 18, no. 12, pp. 4098-4107, 2019.
[37]
F. Edfors et al., "Screening a Resource of Recombinant Protein Fragments for Targeted Proteomics," Journal of Proteome Research, vol. 18, no. 7, pp. 2706-2718, 2019.
[40]
K. Drobin et al., "Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci," Inflammatory Bowel Diseases, vol. 25, no. 2, pp. 306-316, 2019.
[41]
M. Uhlén et al., "The human secretome," Science Signaling, vol. 12, no. 609, 2019.
[43]
Z. Chen et al., "Current applications of antibody microarrays," Clinical Proteomics, vol. 15, 2018.
[46]
G. S. Omenn et al., "Progress on Identifying and Characterizing the Human Proteome : 2018 Metrics from the HUPO Human Proteome Project," Journal of Proteome Research, vol. 17, no. 12, pp. 4031-4041, 2018.
[48]
B. Omazic et al., "A Preliminary Report : Radical Surgery and Stem Cell Transplantation for the Treatment of Patients with Pancreatic Cancer," Journal of immunotherapy (1997), vol. 40, no. 4, pp. 132-139, 2017.
[49]
M. Uhlén et al., "A pathology atlas of the human cancer transcriptome," Science, vol. 357, no. 6352, pp. 660-+, 2017.
[50]
P. J. Thul et al., "A subcellular map of the human proteome," Science, vol. 356, no. 6340, 2017.
[51]
[52]
[53]
E. Pin et al., "Identification of a Novel Autoimmune Peptide Epitope of Prostein in Prostate Cancer," Journal of Proteome Research, vol. 16, no. 1, pp. 204-216, 2017.
[54]
H. Idborg et al., "PROTEIN PROFILING IN PLASMA REVEALS MOLECULAR SUBGROUPS IN SYSTEMIC LUPUS ERYTHEMATOSUS," Annals of the Rheumatic Diseases, vol. 76, pp. A52-A52, 2017.
[55]
[56]
X. Zhou et al., "Thiol–ene–epoxy thermoset for low-temperature bonding to biofunctionalized microarray surfaces," Lab on a Chip, vol. 17, no. 21, pp. 3672-3681, 2017.
[58]
A. Zandian et al., "Whole-Proteome Peptide Microarrays for Profiling Autoantibody Repertoires within Multiple Sclerosis and Narcolepsy," Journal of Proteome Research, vol. 16, no. 3, pp. 1300-1314, 2017.
[59]
U. Qundos et al., "Affinity proteomics discovers decreased levels of AMFR in plasma from Osteoporosis patients," PROTEOMICS - Clinical Applications, vol. 10, no. 6, pp. 681-690, 2016.
[60]
B. Ayoglu et al., "Anoctamin 2 identified as an autoimmune target in multiple sclerosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 8, pp. 2188-2193, 2016.
[61]
B. Ayoglu, J. M. Schwenk and P. Nilsson, "Antigen arrays for profiling autoantibody repertoires," Bioanalysis, vol. 8, no. 10, pp. 1105-1126, 2016.
[62]
A. Häggmark-Månberg et al., "Autoantibody targets in vaccine-associated narcolepsy," Autoimmunity, vol. 49, no. 6, pp. 421-433, 2016.
[63]
J. Remnestål et al., "CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease," PROTEOMICS - Clinical Applications, vol. 10, no. 12, pp. 1242-1253, 2016.
[65]
M. Mikus et al., "Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury," Liver international (Print), vol. 37, no. 1, pp. 132-140, 2016.
[66]
R. Sjöberg et al., "Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling," New Biotechnology, vol. 33, no. 5, pp. 582-592, 2016.
[67]
C. Fredolini et al., "Immunocapture strategies in translational proteomics," Expert Review of Proteomics, vol. 13, no. 1, pp. 83-98, 2016.
[68]
M.-G. Hong et al., "Multidimensional Normalization to Minimize Plate Effects of Suspension Bead Array Data," Journal of Proteome Research, vol. 15, no. 10, pp. 3473-3480, 2016.
[69]
B. Ayoglu et al., "Multiplexed protein profiling by sequential affinity capture," Proteomics, vol. 16, no. 8, pp. 1251-1256, 2016.
[70]
A. Häggmark, J. M. Schwenk and P. Nilsson, "Neuroproteomic profiling of human body fluids," PROTEOMICS - Clinical Applications, vol. 10, no. 4, pp. 485-502, 2016.
[72]
M. J. Iglesias et al., "An affinity proteomics study for plasma biomarker candidates of cardiovascular disease in venous thromboembolism," Journal of Thrombosis and Haemostasis, vol. 13, pp. 956-956, 2015.
[75]
C. Hamsten et al., "Heat differentiated complement factor profiling," Journal of Proteomics, vol. 126, pp. 155-162, 2015.
[76]
K. Papp et al., "Multiplex measurement of autoantibody levels and complement activation in rheumatoid arthritis," Molecular Immunology, vol. 67, no. 1, pp. 170-170, 2015.
[77]
A. Häggmark et al., "Proteomic Profiling Reveals Autoimmune Targets in Sarcoidosis," American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 5, pp. 574-583, 2015.
[78]
M. Uhlén et al., "Tissue-based map of the human proteome," Science, vol. 347, no. 6220, pp. 1260419, 2015.
[79]
M. Bruzelius et al., "Verema - an affinity proteomics study to identify and translate plasma biomarkers for venous thromboembolism," Journal of Thrombosis and Haemostasis, vol. 13, pp. 954-954, 2015.
[80]
S. Byström et al., "Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis," Journal of Proteome Research, vol. 13, no. 11, pp. 4607-4619, 2014.
[81]
J. Bachmann et al., "Affinity Proteomics Reveals Elevated Muscle Proteins in Plasma of Children with Cerebral Malaria," PLoS Pathogens, vol. 10, no. 4, pp. e1004038, 2014.
[82]
B. Ayoglu et al., "Affinity proteomics within rare diseases : a BIO-NMD study for blood biomarkers of muscular dystrophies," EMBO Molecular Medicine, vol. 6, no. 7, pp. 918-936, 2014.
[83]
F. Henjes et al., "Analysis of Autoantibody Profiles in Osteoarthritis Using Comprehensive Protein Array Concepts," Journal of Proteome Research, vol. 13, no. 11, pp. 5218-5229, 2014.
[85]
L. Fagerberg et al., "Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics," Molecular & Cellular Proteomics, vol. 13, no. 2, pp. 397-406, 2014.
[87]
M. Dezfouli et al., "Magnetic bead assisted labeling of antibodies at nanogram scale," Proteomics, vol. 14, no. 1, pp. 14-18, 2014.
[88]
M. Dezfouli et al., "Parallel barcoding of antibodies for DNA-assisted proteomics," Proteomics, vol. 14, no. 21-22, pp. 2432-2436, 2014.
[89]
A. Häggmark et al., "Plasma profiling revelas three proteins associated to amyotrophic lateral sclerosis," Annals of Clinical and Translational Neurology, vol. 1, no. 8, pp. 544-553, 2014.
[90]
A. Danielsson et al., "The Human Pancreas Proteome Defined by Transcriptomics and Antibody-Based Profiling," PLOS ONE, vol. 9, no. 12, pp. e115421, 2014.
[91]
A. Häggmark et al., "Antibody-based profiling of cerebrospinal fluid within multiple sclerosis," Proteomics, vol. 13, no. 15, pp. 2256-2267, 2013.
[92]
B. Ayoglu et al., "Autoantibody profiling in multiple sclerosis using arrays of human protein fragments," Molecular & Cellular Proteomics, vol. 12, no. 9, pp. 2657-2672, 2013.
[93]
L. Fagerberg et al., "Contribution of antibody-based protein profiling to the human chromosome-centric proteome project (C-HPP)," Journal of Proteome Research, vol. 12, no. 6, pp. 2439-2448, 2013.
[94]
K. Drobin, P. Nilsson and J. M. Schwenk, "Highly multiplexed antibody suspension bead arrays for plasma protein profiling," Methods in Molecular Biology, vol. 1023, pp. 137-145, 2013.
[96]
U. Qundos et al., "Profiling post-centrifugation delay of serum and plasma with antibody bead arrays," Journal of Proteomics, vol. 95, no. SI, pp. 46-54, 2013.
[97]
M. Neiman et al., "Selectivity analysis of single binder assays used in plasma protein profiling," Proteomics, vol. 13, no. 23-24, pp. 3406-3410, 2013.
[98]
[99]
K. Colwill et al., "A roadmap to generate renewable protein binders to the human proteome," Nature Methods, vol. 8, no. 7, pp. 551-8, 2011.
[100]
J. M. Schwenk and P. Nilsson, "Antibody suspension bead arrays," Methods in molecular biology (Clifton, N.J.), vol. 723, pp. 29-36, 2011.
[101]
A. Häggmark et al., "Classification of protein profiles from antibody microarrays using heat and detergent treatment.," New Biotechnology, vol. 29, no. 5, pp. 564-570, 2011.
[102]
B. Hjelm et al., "Generation of monospecific antibodies based on affinity capture of polyclonal antibodies," Protein Science, vol. 20, no. 11, pp. 1824-1835, 2011.
[103]
M. Neiman et al., "Plasma Profiling Reveals Human Fibulin-1 as Candidate Marker for Renal Impairment," Journal of Proteome Research, vol. 10, no. 11, pp. 4925-4934, 2011.
[104]
B. Ayoglu et al., "Systematic antibody and antigen-based proteomic profiling with microarrays," EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, vol. 11, no. 2, pp. 219-234, 2011.
[105]
F. Pontén et al., "The Human Protein Atlas as a proteomic resource for biomarker discovery," Journal of Internal Medicine, vol. 270, no. 5, pp. 428-446, 2011.
[106]
R. Sjöberg et al., "Validation of affinity reagents using antigen microarrays," New Biotechnology, vol. 29, no. 5, pp. 555-563, 2011.
[107]
[108]
J. Gantelius et al., "A lateral flow protein microarray for rapid determination of contagious bovine pleuropneumonia status in bovine serum," Journal of Microbiological Methods, vol. 82, no. 1, pp. 11-18, 2010.
[110]
J. M. Schwenk et al., "Comparative protein profiling of serum and plasma using an antibody suspension bead array approach," Proteomics, vol. 10, no. 3, pp. 532-540, 2010.
[111]
J. M. Schwenk et al., "Toward Next Generation Plasma Profiling via Heat-induced Epitope Retrieval and Array-based Assays," Molecular & Cellular Proteomics, vol. 9, no. 11, pp. 2497-2507, 2010.
[112]
K. Larsson et al., "Characterization of PrEST-based antibodies towards human Cytokeratin-17," JIM - Journal of Immunological Methods, vol. 342, pp. 20-32, 2009.
[113]
N. LeBlanc et al., "Development of a magnetic bead microarray for simultaneous and simple detection of four pestiviruses," Journal of Virological Methods, vol. 155, pp. 1-9, 2009.
[114]
J. Rockberg, J. M. Schwenk and M. Uhlén, "Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies," Molecular Oncology, vol. 3, no. 3, pp. 238-247, 2009.
[115]
J. Gantelius et al., "Magnetic bead-based detection of autoimmune responses using protein microarrays.," New biotechnology, vol. 26, pp. 269-276, 2009.
[118]
R. Rimini et al., "Validation of serum protein profiles by a dual antibody array approach," , vol. 73, no. 2, pp. 252-266, 2009.
[119]
J. M. Schwenk et al., "Antibody suspension bead arrays within serum proteomics," Journal of Proteome Research, vol. 7, no. 8, pp. 3168-3179, 2008.
[120]
J. M. Schwenk et al., "Determination of binding specificities in highly multiplexed bead-based assays for antibody proteomics," Molecular & Cellular Proteomics, vol. 6, no. 1, pp. 125-132, 2007.

Kapitel i böcker

[121]
M. J. Iglesias, J. M. Schwenk and J. Odeberg, "Affinity Proteomics Assays for Cardiovascular and Atherosclerotic Disease Biomarkers," in Protein Microarrays for Disease Analysis : Methods and Protocols, : Springer Nature, 2021, pp. 163-179.
[122]
A. Bendes et al., "Bead-Based Assays for Validating Proteomic Profiles in Body Fluids," in Protein Microarrays for Disease Analysis : Methods and Protocols, : Springer Nature, 2021, pp. 65-78.
[123]
R. Sjöberg et al., "High-density antigen microarrays for the assessment of antibody selectivity and off-target binding," in Epitope Mapping Protocols, : Humana Press Inc., 2018, pp. 231-238.
[124]
B. Ayoglu, P. Nilsson and J. M. Schwenk, "Multiplexed antigen bead arrays for the assessment of antibody selectivity and epitope mapping," in Epitope Mapping Protocols, : Humana Press Inc., 2018, pp. 239-248.
[125]
E. Birgersson, J. . M. Schwenk and B. Ayoglu, "Bead-based and multiplexed immunoassays for protein profiling via sequential affinity capture," in Serum/Plasma Proteomics, : Humana Press, 2017, pp. 45-54.
[126]
C. Hellström et al., "High-density serum/plasma reverse phase protein arrays," in Serum/Plasma Proteomics, : Humana Press, 2017, pp. 229-238.
[127]
A. Häggmark-Månberg, P. Nilsson and J. Schwenk, "Neuroproteomic profiling of cerebrospinal fluid (CSF) by multiplexed affinity arrays," in Neuroproteomics : Methods and Protocols, : Humana Press, 2017, pp. 247-254.
[128]
J. M. Schwenk and P. Nilsson, "Assessment of antibody specificity using suspension bead arrays.," in Methods in Molecular Biology, : Springer, 2011, pp. 183-189.

Icke refereegranskade

Artiklar

[130]
M. Persson et al., "Searching for Novel Autoantibodies with Clinical Relevance in Psychiatric Disorders," Schizophrenia Bulletin, vol. 44, pp. S120-S121, 2018.
[131]
D. Djureinovic et al., "Autoantibody Profiles of Cancer-Testis Genes in Non-Small Cell Lung Cancer," Journal of Thoracic Oncology, vol. 12, no. 11, pp. S2002-S2002, 2017.
[132]
L. Lourido et al., "IDENTIFICATION OF A SERUM PROTEIN BIOMARKER PANEL FOR THE DIAGNOSIS OF KNEE OSTEOARTHRITIS," Osteoarthritis and Cartilage, vol. 24, pp. S23-S23, 2016.
[133]
L. Lourido et al., "DISCOVERY OF POTENTIAL SERUM BIOMARKERS IN OSTEOARTHRITIS USING PROTEIN ARRAYS," Annals of the Rheumatic Diseases, vol. 74, pp. 373-374, 2015.
[134]
L. Lourido et al., "Discovery of Novel Serum Biomarkers for Osteoarthritis Using Affinity Proteomics," Arthritis & Rheumatology, vol. 67, 2015.
[135]
B. Ayoglu et al., "Proteomic profiling of the autoimmunity repertoire in multiple sclerosis," New Biotechnology, vol. 29, pp. S20-S20, 2012.
Senaste synkning med DiVA:
2023-02-05 02:20:21